Pannier D(1), Cordoba A(2), Ryckewaert T(1), Robin YM(3), Penel N(4).
(1)Dept of Medical Oncology, Centre Oscar Lambert, Lille, France. (2)Dept of Radiation Oncology, Centre Oscar Lambret, Lille, France. (3)Dept of Bio-Pathology, Centre Oscar Lambret, Lille, France. (4)Medical School, Lille Univ, Lille, France.
Publication
Crit Rev Oncol Hematol
Summary
We review the role of hormonal therapy in the management of different conjunctive tumors. Progestin and aromatase inhibitors seem active in low-grade endometrial stromal sarcoma, but larger case-series are needed. The use of aromatase inhibitor in estrogen-receptor-positive uterine leiomyosarcoma requires further clinical investigation. There is no evidence supporting the use of hormonal therapy in desmoid-type fibromatosis.
Stay Up to Date as We Uncover More About Desmoid Tumors
